LEUKOTAC
Elsalys Biotech
Application Filed: 2018-03-26
Trademark Application Details
SUSPENSION INQUIRY - MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87849391 |
| Registration Number | 6115761 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Michelle P. Ciotola |
| Attorney Name | Michelle P. Ciotola |
| Attorney Docket Number | GER2992TUS |
| Law Office Assigned | L20 |
| Employee Name | GARTNER, JOHN M |
Timeline
| 2018-03-26 | Application Filed |
| 2019-08-28 | Location: TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED |
| 2019-08-28 | Status: Live/Pending |
| 2019-08-28 | Transaction Date |
| 2020-08-04 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  ELSALYS BIOTECH |
| Entity Statement | société par actions simplifiée (sas) |
| Address | 317 avenue Jean Jaurès LYON FR 69007 |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for immuno-oncology and autoimmune disease; pharmaceutical preparations namely immunotherapy monoclonal antibodies; veterinary preparations for immuno-oncology and autoimmune disease; veterinary preparations namely immunotherapy monoclonal antibodies; biotechnological preparations for medical and veterinary use, namely, immunotherapy monoclonal antibodies |
| GS0051 | Pharmaceutical preparations for immuno-oncology and autoimmune disease; pharmaceutical preparations, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; veterinary preparations for immuno-oncology and autoimmune disease; veterinary preparations, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases; biotechnological preparations for medical and veterinary use, namely, immunotherapy monoclonal antibodies for immuno-oncology and for the treatment of autoimmune diseases |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-03-29 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-04-02 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-07-11 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-07-12 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-07-12 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-07-12 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-01-14 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2019-01-17 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-01-17 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-01-17 | 10 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2019-02-28 | 11 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2019-02-28 | 12 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-02-28 | 13 GNS3 O:Outgoing Correspondence |
| SUSPENSION INQUIRY WRITTEN | 2019-08-28 | 14 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2019-08-28 | 15 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2019-08-28 | 16 GNS2 O:Outgoing Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-02-24 | 17 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-02-24 | 18 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-02-24 | 19 ARAA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-02-24 | 20 CHAN I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-02-24 | 21 TCCA I:Incoming Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2020-02-24 | 22 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-26 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-26 | 24 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2020-04-03 | 25 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2020-04-03 | 26 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2020-04-03 | 27 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2020-04-10 | 28 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-10 | 29 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-10 | 30 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-04-14 | 31 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-04-29 | 32 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2020-05-19 | 33 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-05-19 | 34 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-08-04 | 35 R.PR A:Allowance for Publication |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2024-01-24 | 36 ASGN I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LEUKOTAC 87849391 not registered Live/Pending |
ELSALYS BIOTECH 2018-03-26 |
 LEUKOTAC 75220942 not registered Dead/Abandoned |
BIOTEST AG 1997-01-03 |
 LEUKOTAC 74436071 not registered Dead/Abandoned |
BIOTEST AG 1993-09-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 